EUVIMEDEUVIMED entdecken
Crossref

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era

Hiroki Hosoi iD, Misato Tane, Tadashi Okamura, Shotaro Tabata, Ke Wan, Shogo Murata, Toshiki Mushino, Akinori Nishikawa, Takashi Sonoki

Transplant Infectious Disease · 2025

DOI: 10.1111/tid.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Hiroki Hosoi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Length of Stay, Antiviral Agents. Die Arbeit nennt 19 Literaturangaben. Gefördert von: JSPS KAKENHI, Takeda Science Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In recent years, letermovir has been routinely used for cytomegalovirus (CMV) infection prophylaxis in patients receiving allogeneic hematopoietic stem‐cell transplantation (HSCT). The reduction effect of letermovir on CMV infection rates and the impact on survival have been studied, but other potential benefits of letermovir remain underexplored.

Methods

This retrospective study included patients who underwent first‐time allogeneic HSCT between October 2013 and August 2023. We compared the length of hospital stay between eras before and after the introduction of letermovir (“nonletermovir group” and “letermovir group,” respectively). Secondary outcomes included clinically significant CMV infection rates and hospitalization costs.

Results

A total of 59 patients were analyzed in the nonletermovir group and 65 patients in the letermovir group. The median length of hospital stay was 51 days in the nonletermovir group and 42 days in the letermovir group ( p < 0.001). Among standard‐risk disease patients, the letermovir group also had significantly shorter hospital stays ( p = 0.0048). Additionally, the cumulative incidence of clinically significant CMV infection and grade II–IV acute graft‐versus‐host disease were both lower in the letermovir group. Hospitalization costs were not significantly different between the two groups.

Conclusion

The length of hospital stays after HSCT was observed to be shorter following the introduction of letermovir in this study. This reduction in hospital stays did not decrease hospitalization costs in relation to allogeneic HSCT, but it may alleviate the burden on both patients and healthcare providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCytomegalovirus InfectionsLength of StayAntiviral AgentsAcetatesQuinazolinesHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTransplantation, HomologousGraft vs Host DiseaseAged

Stichwörter der Autor:innen

cytomegalovirushospital stayletermovirtransplantation

Substanzen

letermovirAntiviral AgentsAcetatesQuinazolines

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
  • Department of Transfusion Medicine, Wakayama Medical University Hospital, Wakayama, Japan.
  • Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan.
  • Division of Medical Information, Wakayama Medical University Hospital, Wakayama, Japan.

ORCID-Profile: Hiroki Hosoi

Förderung

  • JSPS KAKENHI
  • Takeda Science Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Hosoi, H., Tane, M., Okamura, T., Tabata, S., Wan, K., Murata, S., Mushino, T., Nishikawa, A., & Sonoki, T. (2025). Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era. Transplant Infectious Disease. https://doi.org/10.1111/tid.70008

Vancouver

Hosoi H, Tane M, Okamura T, Tabata S, Wan K, Murata S, et al. Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era. Transplant Infectious Disease. 2025. doi:10.1111/tid.70008

BibTeX
@article{Hosoi2025,
  author = {Hosoi, Hiroki and Tane, Misato and Okamura, Tadashi and Tabata, Shotaro and Wan, Ke and Murata, Shogo and Mushino, Toshiki and Nishikawa, Akinori and Sonoki, Takashi},
  title = {Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era},
  journal = {Transplant Infectious Disease},
  year = {2025},
  doi = {10.1111/tid.70008}
}
Kostenlos starten →